Best Practice for Late Stage Funding - Kameel Farag, Hari Pujar, Randy Berholtz

Our expert panel of C-level executives and board members reveal their tips tricks for successful late stage funding rounds. Great insight from:

Hari Pujar - Operating Partner at Flagship Therapeutics and COO at Tessera Therapeutics 

Randy Berholtz - Chair and Chief Executive Officer Chair and Chief Executive Officer - Rancho Santa Fe Bio, Inc.

Kameel Farag - CFO Aspen NeuroScience 

Hosted by Jared Green and Alex Cooke from Phase 3 Search 

www.ph3.bio